GLP-1 SG is supplied in a lyophilized vial format and available in 10mg, 20mg, and 30mg strengths. Each vial includes lot-based traceability and tamper-evident packaging for consistency across research workflows.
| Strength | Lot # | Content | Purity | Tested |
|---|---|---|---|---|
| 10mg | PA-2025-002 | 11.22mg | 99.591% | Dec 27, 2024 |
| 20mg | PA-2025-003 | 21.48mg | 99.619% | Dec 27, 2024 |
| 30mg | PA-2025-004 | 33.47mg | 99.541% | Jan 14, 2025 |
GLP-1 SG is supplied in a lyophilized vial format and available in 10mg, 20mg, and 30mg strengths. Each vial includes lot-based traceability and tamper-evident packaging for consistency across research workflows.
| Strength | Lot # | Content | Purity | Tested |
|---|---|---|---|---|
| 10mg | PA-2025-002 | 11.22mg | 99.591% | Dec 27, 2024 |
| 20mg | PA-2025-003 | 21.48mg | 99.619% | Dec 27, 2024 |
| 30mg | PA-2025-004 | 33.47mg | 99.541% | Jan 14, 2025 |
GLP-1 SG is a semaglutide-class GLP-1 receptor agonist supplied in a lyophilized vial format for laboratory research applications. Available in 10mg, 20mg, and 30mg strengths, each vial includes lot-based traceability and tamper-evident packaging for consistent laboratory research workflows.
GLP-1 SG is a semaglutide-class GLP-1 receptor agonist investigated in laboratory research related to incretin signaling, glucose homeostasis, and appetite regulation.
A lyophilized (freeze-dried) powder in a sealed glass vial, ready for reconstitution per your lab’s protocol.
Every vial carries an internal lot code tied to our traceability log, plus tamper-evident sealing maintained from fulfillment through delivery.
No. This product is sold strictly for laboratory research use by qualified researchers, and is not a drug, dietary supplement, or medical device.
Certificate of analysis documentation is available for all three strengths, with results published to the product page.
Orders are prepared from lot-tracked inventory and shipped in tamper-evident packaging with tracking information.
| Size | 10mg, 20mg, 30mg |
|---|